OUR VISION:

Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Green Bay Packers and Cologuard Launch Colon Cancer Awareness Campaign

Pledging to help increase screening offers fans opportunity to win Packers tickets and prizes GREEN BAY and MADISON, Wis. – Aug. 16, 2017 – The Green Bay Packers and Exact Sciences, the manufacturer of Cologuard, are teaming up to promote colorectal cancer awareness throughout the 2017 football season.  Colon cancer took the life of legendary Packers coach Vince Lombardi at age 57 and almost...Read more

Continued Momentum Through the Second Quarter

Exact Sciences recently announced 2017 second quarter earnings results, which exceeded our expectations. Revenue reached $57.6 million, up 19% sequentially, and completed Cologuard test volume totaled 135,000, up 35% sequentially. Second quarter cost of sales totaled $133 per completed Cologuard test, down from $170 in the first quarter and significantly better than we expected. During the...Read more

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com